Behavioral treatment program for managing type 2 diabetes
COntinuous Glucose Monitoring, Contingency Management, and Motivational InTerviewing for Patients With TypE 2 Diabetes in Kansas City
NA · University of Missouri, Kansas City · NCT06374186
This study is testing a new program that combines coaching, rewards, and glucose monitoring to see if it helps adults with type 2 diabetes manage their blood sugar better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University of Missouri, Kansas City (other) |
| Locations | 1 site (Kansas City, Missouri) |
| Trial ID | NCT06374186 on ClinicalTrials.gov |
What this trial studies
This study evaluates a behavioral treatment program that combines diabetes coaching, financial rewards, and continuous glucose monitoring to enhance diabetes management in adults with type 2 diabetes. Participants will be randomly assigned to either the intervention group, which receives the behavioral treatment, or a control group. All participants will use a Continuous Glucose Monitor (CGM) to track their blood sugar levels, with the intervention group receiving contingency management rewards based on their adherence to treatment. The goal is to determine if this approach improves blood sugar management and adherence to diabetes treatment plans.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 diagnosed with type 2 diabetes and having a recent hemoglobin A1c level between 8.0 and 11.0.
Not a fit: Patients with type 1 diabetes, secondary diabetes, or those with certain psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve blood sugar control and treatment adherence for patients with type 2 diabetes.
How similar studies have performed: Other studies have shown promise in using behavioral interventions and continuous glucose monitoring for diabetes management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosed with type 2 diabetes 2. Age 18 to 65 3. Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months 4. Most recent hemoglobin A1c result between 8.0 and 11.0 5. Currently receiving treatment for diabetes by a licensed healthcare provider. 6. Reliable access to a personal smart phone that is compatible with CGM 7. English speaking Exclusion Criteria: 1. Type 1 diabetes 2. Secondary type 2 diabetes (diagnosis secondary to other medical conditions such as pancreatitis, Cystic Fibrosis, or Cushing disease) 3. Prescribed short-acting (mealtime) insulin as part of diabetes treatment plan 4. Known or acknowledged active substance use disorder or that would interfere or negatively impact participation in the study 5. Diagnosis of a medical/psychiatric condition that would prevent participation in the study (e.g., Intellectual Disability, Alzheimer's disease, Traumatic Brain Injury, Schizophrenia)
Where this trial is running
Kansas City, Missouri
- University of Missouri - Kansas City School of Medicine — Kansas City, Missouri, United States (RECRUITING)
Study contacts
- Principal investigator: Jared Bruce, PhD — University of Missouri, Kansas City
- Study coordinator: Carrie Kriz, MS
- Email: mckinleycr@umkc.edu
- Phone: 816-512-7473
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type 2 Diabetes, Glucose, contingency management, motivational interviewing